Tackling Parkinson's Disease as a Global Challenge

Roongroj Bhidayasiri^{1

2}, Lorraine V Kalia^{3

4}, Bastiaan R Bloem⁵

Affiliations

¹ Chulalongkorn Centre of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
² The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.
³ Division of Neurology, Department of Medicine, Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.
⁴ Krembil Research Institute, Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Toronto, Canada.
⁵ Radbound University Nijmegen Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, The Netherlands.

Editorial

Roongroj Bhidayasiri et al. J Parkinsons Dis. 2023.

. 2023;13(8):1277-1280.

doi: 10.3233/JPD-239005.

Roongroj Bhidayasiri^{1

2}, Lorraine V Kalia^{3

4}, Bastiaan R Bloem⁵

¹ Chulalongkorn Centre of Excellence for Parkinson's Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
² The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.
³ Division of Neurology, Department of Medicine, Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.
⁴ Krembil Research Institute, Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Toronto, Canada.
⁵ Radbound University Nijmegen Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, The Netherlands.

No abstract available

Keywords: Parkinson’s disease; Parkinson’s pandemic; global neurology; low-to-middle income countries.

Conflict of interest statement

None of the authors have any conflicts of interest to report that are relevant to this publication.

1. Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The Emerging Evidence of the Parkinson Pandemic. J Parkinsons Dis 8, S3–S8. - PMC - PubMed
1. Schiess N, Cataldi R, Okun MS, Fothergill-Misbah N, Dorsey ER, Bloem BR, Barretto M, Bhidayasiri R, Brown R, Chishimba L, Chowdhary N, Coslov M, Cubo E, Di Rocco A, Dolhun R, Dowrick C, Fung VSC, Gershanik OS, Gifford L, Gordon J, Khalil H, Kuhn AA, Lew S, Lim SY, Marano MM, Micallef J, Mokaya J, Moukheiber E, Nwabuobi L, Okubadejo N, Pal PK, Shah H, Shalash A, Sherer T, Siddiqui B, Thompson T, Ullrich A, Walker R, Dua T (2022) Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority. JAMA Neurol 79, 929–936. - PubMed
1. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68, 384–386. - PubMed
1. Rocca WA (2018) The future burden of Parkinson’s disease. Mov Disord 33, 8–9. - PMC - PubMed
1. Rossi A, Berger K, Chen H, Leslie D, Mailman RB, Huang X (2018) Projection of the prevalence of Parkinson’s disease in the coming decades: Revisited. Mov Disord 33, 156–159. - PMC - PubMed